This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,996.61 firm fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance ending on January 2, 2025.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award for XIFAXAN 550 MG TABLET 60S is likely a delivery order issued against that larger IDC. The contract does not have a set-aside designation, indicating open competition.
Generated 4/1/25, 10:36 PM